
POLAREAN IMAGING PLC
POLX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BF3DT583
- LEI:
- 213800DGR2BHXJ36OL37
- Country:
- United States of America
- Address:
- 2500 MERIDIAN PARKWAY, 27713 DURHAM
- Website:
- https://polarean.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Poolbeg Pharma develops and commercializes innovative medicines for unmet medical needs, focusing on cancer immunotherapy-induced CRS, infectious diseases, and metabolic conditions.Ê They strategically commercialize existing drugs to fund their pipeline and leverage AI to accelerate drug discovery.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-08-12 08:00 |
Legal Proceedings Report
Submission of new Phase III study protocol to FDA
|
English | 20.5 KB | |
2025-07-24 08:00 |
Remuneration Information
Block Listing Six Monthly Return
|
English | 22.2 KB | |
2025-06-24 08:00 |
Related Party Transaction
Promotion & sales representative agreement
|
English | 20.2 KB | |
2025-06-02 08:00 |
Regulatory News Service
FDA expands XENOVIEW indication
|
English | 21.0 KB | |
2025-05-15 13:48 |
Regulatory News Service
Xenon MRI featured prominently at ATS 2025
|
English | 51.6 KB | |
2025-05-14 15:25 |
Environmental & Social Information
Ongoing collaboration with Philips
|
English | 13.0 KB | |
2025-03-10 08:00 |
Regulatory News Service
Expansion of Xenon MRI imaging platform
|
English | 22.6 KB | |
2025-02-27 08:00 |
Earnings Release
FY24 trading update
|
English | 20.3 KB | |
2025-02-19 08:00 |
Regulatory News Service
Virtual Investor Day
|
English | 19.5 KB | |
2025-02-03 08:00 |
M&A Activity
Taiwanese distributor agreement with Sumtage
|
English | 18.7 KB | |
2025-01-30 08:00 |
Regulatory News Service
Key patent in China secured
|
English | 17.5 KB | |
2025-01-28 08:00 |
Regulatory News Service
Collaboration to Advance Lung Imaging Innovation
|
English | 22.2 KB | |
2025-01-24 08:00 |
Share Issue/Capital Change
Block Listing Six Monthly Return
|
English | 22.3 KB | |
2024-12-11 15:52 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.4 KB | |
2024-11-21 08:00 |
Regulatory News Service
FDA clears Chest Coil in GE HealthCare MRI Systems
|
English | 20.0 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
Double Bond Pharmaceutical International AB | Sweden | DBP B | |
|
Eckert & Ziegler Strahlen- und Medizintechnik AG | Germany | EUZ | |
![]() |
Ectin Research AB | Sweden | ECTIN B | |
![]() |
Elanix Biotechnologies AG | Germany | ELN | |
![]() |
Elbit Meditec-M Ltd. | Israel | EMTC-M | |
![]() |
Elicera Therapeutics AB | Sweden | ELIC | |
![]() |
Elron Ventures Ltd. | Israel | ELRN | |
![]() |
Enlivex Therapeutics Ltd. | Israel | ENLV | |
![]() |
ERYTECH Pharma S.A. | France | ERYP | |
![]() |
Eurobio Scientific | France | ALERS |